Literature DB >> 17151938

Mixture modeling for the detection of subpopulations in a pharmacokinetic/pharmacodynamic analysis.

Annabelle Lemenuel-Diot1, Christian Laveille, Nicolas Frey, Roeline Jochemsen, Alain Mallet.   

Abstract

To be able to estimate accurately parameters entering a non-linear mixed effects model taking into account that one or more subpopulations of patients can exist rather than assuming that the entire population is best described by unimodal distributions for the random effects, we proposed a methodology based on the likelihood approximation using the Gauss-Hermite quadrature. The idea is to combine the estimation of the model parameters and the detection of homogeneous subgroups of patients in a given population using a Gaussian mixture for the distribution of the random effects. As the accuracy of the likelihood approximation is likely to govern the quality of the estimation of the different parameters entering the non-linear mixed effects model, we based this approximation on the use of an adjustable Gauss-Hermite quadrature. Moreover, to complete this methodology, we propose a strategy allowing the detection and explanation of heterogeneity based on the Kullback-Leibler test, which was used to estimate the number of components in the Gaussian mixture. In order to evaluate the capability of the method to take into account heterogeneity, this strategy was performed in a PK/PD analysis using the database and the structural model selected in a previous analysis. In this analysis, non-responders were found out using NONMEM [Beal and Sheiner. NONMEM Users Guides. NONMEM Project Group, University of California, San Francisio, 1992] in a population of diabetic patients treated with a once-a-day new formulation of an antidiabetic drug. The authors looked for a subpopulation of patients for whom the therapeutic effect would vanish. In this paper, we looked for subpopulations of patients exhibiting specificities with respect to different parameters entering the description of the effect. The results obtained with our approach are compared in terms of parameter estimation and heterogeneity detection to those obtained in the previous analysis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17151938     DOI: 10.1007/s10928-006-9039-8

Source DB:  PubMed          Journal:  J Pharmacokinet Pharmacodyn        ISSN: 1567-567X            Impact factor:   2.745


  6 in total

1.  Mixed Poisson regression models with covariate dependent rates.

Authors:  P Wang; M L Puterman; I Cockburn; N Le
Journal:  Biometrics       Date:  1996-06       Impact factor: 2.571

2.  Population PKPD modelling of the long-term hypoglycaemic effect of gliclazide given as a once-a-day modified release (MR) formulation.

Authors:  N Frey; C Laveille; M Paraire; M Francillard; N H G Holford; Roeline Jochemsen
Journal:  Br J Clin Pharmacol       Date:  2003-02       Impact factor: 4.335

3.  Estimating heterogeneity in random effects models for longitudinal data.

Authors:  A Lemenuel-Diot; A Mallet; C Laveille; R Bruno
Journal:  Biom J       Date:  2005-06       Impact factor: 2.207

Review 4.  Recent developments in computer-assisted analysis of mixtures.

Authors:  D Böhning; E Dietz; P Schlattmann
Journal:  Biometrics       Date:  1998-06       Impact factor: 2.571

5.  Estimating probability of non-response to treatment using mixture distributions.

Authors:  M Pavlic; R J Brand; S R Cummings
Journal:  Stat Med       Date:  2001-06-30       Impact factor: 2.373

6.  Evaluation of mixture modeling with count data using NONMEM.

Authors:  Bill Frame; Raymond Miller; Richard L Lalonde
Journal:  J Pharmacokinet Pharmacodyn       Date:  2003-06       Impact factor: 2.745

  6 in total
  4 in total

1.  Population pharmacokinetic modeling of risperidone and 9-hydroxyrisperidone to estimate CYP2D6 subpopulations in children and adolescents.

Authors:  Catherine M T Sherwin; Shannon N Saldaña; Robert R Bies; Michael G Aman; Alexander A Vinks
Journal:  Ther Drug Monit       Date:  2012-10       Impact factor: 3.681

2.  Population Pharmacokinetic Modelling for Estimation of Remifentanil Metabolic-Ratio Using Non-steady-State Concentrations under Rapidly Adaptive Dosing.

Authors:  Monica Simeoni; Chao Chen
Journal:  Pharm Res       Date:  2018-09-25       Impact factor: 4.200

3.  Population Pharmacokinetic/Pharmacodyanamic Mixture Models via Maximum a Posteriori Estimation.

Authors:  Xiaoning Wang; Alan Schumitzky; David Z D'Argenio
Journal:  Comput Stat Data Anal       Date:  2009-10-01       Impact factor: 1.681

4.  Pharmacokinetic and pharmacodynamic modeling of oral mitiglinide on glucose lowering in healthy Chinese volunteers.

Authors:  Shijia Liu; Peidong Chen; Yang Zhao; Guoliang Dai; Bingting Sun; Yao Wang; Anwei Ding; Wenzheng Ju
Journal:  BMC Pharmacol Toxicol       Date:  2017-07-04       Impact factor: 2.483

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.